Leibowitz Arthur S

SEC Form 4 insider trading activity

Leibowitz Arthur S has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 11, 2026.

On the most recent filing, Leibowitz Arthur S is listed as Director at Organogenesis Holdings Inc. Inside the rolling window, Leibowitz Arthur S reported 1 open-market purchase totaling $13K in ORGO and no open-market sales.

Companies traded

Other insiders at ORGO

Insider Buying

$13K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ORGO
Leibowitz Arthur S
Purchase$13KMar 11SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Leibowitz Arthur S made?

Leibowitz Arthur S has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.

Which companies does Leibowitz Arthur S trade?

Leibowitz Arthur S has filed SEC Form 4 disclosures for 1 company, including ORGO.

When was Leibowitz Arthur S's most recent SEC Form 4 filing?

Leibowitz Arthur S's most recent SEC Form 4 filing on Tracefour is dated Mar 11, 2026.

What is Leibowitz Arthur S's total buy and sell value in the current window?

Inside the rolling retention window, Leibowitz Arthur S bought $13K and sold $0 based on SEC Form 4 filings.

What was Leibowitz Arthur S's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 5,000 ORGO shares on 2026-03-09, worth $13K, per SEC Form 4 filings.